Sep 19, 2023 In the News BioGenerator Company Aclaris Announces Positive Phase 1 Data for ITK/JAK3 inhibitor
Aug 26, 2023 In the News Managing Director of BioGenerator Ventures, Matt Helms, Builds Unique Ag-Food Business
Aug 15, 2023 In the News BioGenerator Company Wugen Begins Phase 1 Clinical Trial of Allogeneic Memory Natural Killer (NK) Cell Therapy
May 18, 2023 In the News BioGenerator Company Immunophotonics Receives Green Light from FDA to Open IND
Feb 6, 2023 In the News BioGenerator Company KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product
Feb 3, 2023 In the News BioGenerator Company Agragene using CRISPR to Reduce Reliance on Pesticides - Help Protect Billion-Dollar Industries
